FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: ValueSet/2.16.840.1.113883.3.464.1003.1057

Packageus.nlm.vsac
Resource TypeValueSet
Id2.16.840.1.113883.3.464.1003.1057
FHIR VersionR4
Sourcehttp://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.464.1003.1057/expansion
URLhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1057
Version20210909
Statusactive
Date2021-09-09T01:01:23-04:00
NameMeprobamateMedications
TitleMeprobamate Medications
Realmus
Authorityhl7
Purpose(Clinical Focus: The purpose of this value set is to represent concepts for meprobamate medications.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use and prescribable medications.),(Exclusion Criteria: Excludes concepts that represent non-prescribable or branded drugs and excludes concepts that represent components or ingredients.)

Resources that use this resource

No resources found


Resources that this resource uses

CodeSystem
rxnormRxNorm
ValueSet
2.16.840.1.113883.3.464.1003.196.11.1256Meprobamate Medications

Narrative

No narrative content found in resource


Source

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.464.1003.1057",
  "meta": {
    "versionId": "5",
    "lastUpdated": "2024-01-09T11:26:36.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "NCQA PHEMUR Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2025-02-04"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2021-09-09"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1057",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113883.3.464.1003.1057"
    }
  ],
  "version": "20210909",
  "name": "MeprobamateMedications",
  "title": "Meprobamate Medications",
  "status": "active",
  "experimental": false,
  "date": "2021-09-09T01:01:23-04:00",
  "publisher": "NCQA PHEMUR",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: The purpose of this value set is to represent concepts for meprobamate medications.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use and prescribable medications.),(Exclusion Criteria: Excludes concepts that represent non-prescribable or branded drugs and excludes concepts that represent components or ingredients.)",
  "compose": {
    "include": [
      {
        "valueSet": [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1256"
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:10bc4a07-1072-4f34-bb0a-746eba0d4395",
    "timestamp": "2025-05-23T22:13:45-04:00",
    "total": 2,
    "contains": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "197928",
        "display": "meprobamate 200 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "197929",
        "display": "meprobamate 400 MG Oral Tablet"
      }
    ]
  }
}